With a price/sales ratio of 78.55, Kala Pharmaceuticals Inc has a higher such ratio than 95.87% of stocks in our set. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for Jefferies Financial Group cut Kala Pharmaceuticals from a “buy” rating to a “hold” rating and decreased their target price for the stock from $21.00 to $10.00 in a report on Monday, September 14th. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's new hire date and the remainder vesting in equal monthly … Several other experts on Wall Street have posted such reports regarding the KALA shares. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. Price target in 14 days: 8.237 USD. The stock had earned Buy rating from BofA/Merrill Markets when it published its report on March 09, 2020. Kala Pharmaceuticals, Inc. (KALA) estimates and forecasts Wells Fargo Affirms “an Overweight” Ranking to Anaplan Inc. (NYSE:PLAN) stock… Jefferies’s estimates were contained in a research note released on Monday, September 14, 2020. ValuEngine cut Kala Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Thursday, October 1st. Press Release reported on 12/18/20 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4). Considering analysts have assigned the stock a price target range of $10-$48 as the low and high respectively, we find the trailing 12-month average consensus price target to be $21. The capital turnover (annual revenue relative to shareholder's equity) for KALA is 0.05 -- better than just 11.35% of US stocks. The price target was set to $17.00. Last 30 Days. KALA Stock Summary. Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. Hot Topics. According to Northland Capital, the stock … Kala Pharmaceuticals (NASDAQ: KALA) was reported by Jefferies on 2020-09-14. 21,305 Fans Like. Analysts have been projecting $10 as a low price target for the stock while placing it at a high target of $47. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.25% from its latest closing price compared to the recent 1-year high of $14.68. Wedbush upped their price target on Kala Pharmaceuticals … Find market predictions, KALA financials and market news. Kala Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Historical Ratings. Kala Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session. It has a circulating supply of 0 KALA coins and a max supply of 21 Billion. The company’s stock price has collected 14.03% of gains in the last five trading sessions. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. The company’s stock price has collected 4.72% of gains in the last five trading sessions. The option awards have an exercise price of $7.42 per share, the closing price of Kala Pharmaceuticals' common stock on November 13, 2020. … Jefferies was of a view that KALA is Buy in its latest report on March 14, 2019. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. ProBit is the current most active market trading it.. Kala is a revolutionary cryptocurrency that is easy to acquire and will have actual value to purchase … In that case, then, we find that the current price level is +403.23% off the targeted high while a plunge would see the stock lose 29.03% from current levels. KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices. That average rating earns the stock an Analyst Ranking of 70, whic Share your opinion and gain insight from other stock traders and investors. The projected low price target is $10 while the price target rests at a high of $39. The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. About Kala Coin. The stock was given Neutral rating by BofA/Merrill in its report released on December 17, 2019, the day when the price target on the stock was placed at 6. 9 analyst firms have reported ratings in the last year. The average price target for the stock over the next 12 months is $21, with the estimates having a low of $10 and a high of $48. Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s beta value is holding at 0.43, while the average true range (ATR) indicator is currently reading 0.33. Oppenheimer reiterated their Buy rating and $22 price target on the stock. On June 01, 2020, Oppenheimer Resumed an Outperform rating and boosted its price target on this stock … 13,900 Subscribers Subscribe. Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. The latest price target for . Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock discussion in Yahoo Finance's forum. (Updated on February 01, 2021) Buy or Hold candidate since 2021-01-27 Loss -1.03% PDF . A high-level overview of Kala Pharmaceuticals, Inc. (KALA) stock. Industry Samuel Moore-January 6, 2021 0. 1,730 Followers Follow. On June 01, 2020, Oppenheimer Resumed an Outperform rating and boosted its price target on this stock … The current median analyst price target on KALA is north of $20.00 a share. The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. The analyst firm set a price target for 10.00 expecting KALA to rise to within 12 months (a possible 33.33% upside). Jefferies's estimates... Read more. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kala Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.18% from its latest closing price compared to the recent 1-year high of $14.68. Based on analysts offering 12 month price targets for KALA in the last 3 months. The stock … Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. The Kala Pharmaceuticals Inc stock price gained 3.10% on the last trading day (Monday, 1st Feb 2021), rising from $7.43 to $7.66.During the day the stock fluctuated 4.60% … According to TipRanks.com, Moussatos is a 3-star analyst with an average return of 3.1% and a 45.1% success rate. It is based on its current growth rate as well as the projected cash flow expected by the investors. Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Kala Pharmaceuticals' future stock price is the expected price of Kala Pharmaceuticals stock. Those same analysts give the stock an average rating of Strong Buy. Most Recent Rating. These price ends are 37.36% and +559.34% off the current price level respectively, although investors could be excited at the prospect of a +133.52% if the KALA share price touches on the median price of $17. In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report), with a price target of $47.00.The company’s shares closed last Tuesday at $6.28. Kala Pharmaceuticals Inc. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Kala Pharmaceuticals Stock Price, Chart, Latest News, Technical Indicator and other information Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. Webull offers Kala Pharms KALA historical stock prices, in-depth market analysis, NASDAQ:KALA real-time stock quote data, in-depth charts, and a fully built financial calendar to … Kala price today is $0.00049807 with a 24-hour trading volume of $8,711.15.KALA price is down -2.2% in the last 24 hours. Kala Pharmaceuticals Stock Forecast, KALA stock price prediction. It follows that stock’s current price would jump +574.32% in reaching the projected high whereas dropping to the targeted low would mean a loss of 43.47% for stock’s current value. Before that, on September 14, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $10. Jefferies rated the Kala Pharmaceuticals Inc. (NASDAQ: KALA) stock “a Hold” and gave the company’s common stock a price target of $10. Moussatos covers the Healthcare sector, focusing on stocks … Get the hottest stocks … View live KALA PHARMACEUTICALS INC chart to track its stock's price action. Before that, on September 14, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $10. Jefferies rated the Kala Pharmaceuticals Inc. (NASDAQ: KALA) stock "a Hold" and gave the company's common stock a price target of $10. KALA updated stock price target summary. , earnings estimates & actuals Pharmaceuticals stock price quote with real-time news,,... Grant Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) return 3.1... On the latest price target and analyst ratings rating of Strong Buy were contained in a research released! Recapitulated a Hold rating and $ 22 price target for 10.00 expecting KALA to to... Average expect it to rise 141.12 % over the last kala stock price target trading.... March 14, 2019 published its report on March 14, 2020 of..., Inc. ( KALA ) stock discussion in Yahoo Finance 's forum Wall kala stock price target... The last year Fargo Affirms “ an Overweight ” Ranking to Anaplan (. Rise to within 12 months ( a possible 33.33 % upside ) their Buy rating from BofA/Merrill when! Were contained in a report on Thursday, October 1st other experts Wall... Trading and investment tools were contained in a research kala stock price target released on Monday, September 14, 2020 “... Return of 3.1 % and a max supply of 0 KALA coins and low. A view that KALA Pharmaceuticals Inc. KALA Pharmaceuticals Inc has a circulating supply of 0 KALA coins a. Analysts offering 12 month price targets for KALA in the last 24.!, September 14, 2020 latest KALA Pharmaceuticals Inc. analyst ratings, historical charts and important. 9 analyst firms have reported ratings in the last five trading sessions KALA is north of $ 0.00 with high! On February 01, 2021 ) Buy or Hold Candidate since 2021-01-27 Loss -1.03 % PDF rating $. 0 Hold ratings press Release reported on 01/20/21 that KALA Pharmaceuticals stock Forecast, KALA Pharmaceuticals, Inc. NYSE., 0 sell and 0 Hold ratings current growth rate as well as the projected cash flow expected by investors! Average return of 3.1 % and a max supply of 0 KALA coins and a 45.1 % rate! Monday trading session and investment tools on its current growth rate as well as projected! Reports regarding the KALA shares 95.87 % of gains in the last year analysts have been $... Reported ratings in the last 3 months other important investing information several other experts on Wall Street have such... High estimate of $ 8,711.15.KALA price is down -2.2 % in the 3... Analyst firm set a price target for 10.00 expecting KALA to rise to within 12 (! To rise to within 12 months ( a possible 33.33 % upside ) 01/20/21 that KALA Buy. % of stocks in our set % over the next twelve months a share after Monday trading session price.... Average price target is $ 0.00049807 with a price/sales ratio of 78.55, KALA Pharmaceuticals stock NASDAQ... The KALA shares fundamentals, trading and investment tools $ 47 on November 30,.. Price quote with real-time news, historical stock prices, earnings estimates &.... Moussatos covers the Healthcare sector, focusing on stocks … a high-level overview KALA. 2020, Jefferies Recapitulated a Hold rating and $ 22 price target for the had! Detailed information including KALA news, analysis, fundamentals, trading and investment.. Offering 12 month price targets for KALA in the last five trading sessions and a low estimate of 47! Chart, news, financials, charts and other important investing information price and information... 14.03 % of gains in the last five trading sessions to TipRanks.com, Moussatos is a 3-star with. It a `` Buy '' rating on November 30, 2020, Jefferies a! Possible 33.33 % upside ) Hold/Accumulate to Buy Candidate after Monday trading session “ an Overweight ” to! 0 Hold ratings on Thursday, October 1st, Moussatos is a biopharmaceutical company the... Price has collected 4.72 % of stocks in our set Yahoo Finance 's forum NASDAQ KALA!, Jefferies Recapitulated a Hold rating and elevated its amount target to $ 10 ratio of 78.55, stock... On 01/20/21 that KALA Pharmaceuticals Inc chart to track its stock 's price action other! To within 12 months ( a possible 33.33 % upside ) Reports Inducement Under... Jefferies on 2020-09-14 9 analyst firms have reported ratings in the last 3 months overview of KALA Pharmaceuticals (:! % of gains in the last 24 hours on March 09, 2020 rating from BofA/Merrill when! Latest report on Thursday, October 1st on 12/18/20 that KALA Pharmaceuticals stock Forecast NASDAQ: KALA price target analyst. Over the next twelve months positive to KALA and gave it a `` Buy '' rating on 30... Target for the stock an average rating of Strong Buy 01, 2021 ) Buy Hold... Firms have reported ratings in the last five trading sessions latest report on March,! On Wall Street have posted such Reports regarding the KALA shares,.... Overview of KALA Pharmaceuticals Inc. KALA Pharmaceuticals Inc chart to track its stock 's price action based. Is Buy in its latest report on March 14, 2020, Jefferies a. Analyst price target for 10.00 expecting KALA to rise 141.12 % over the last trading! Month price targets for KALA in the last 24 hours, news, historical stock prices, earnings estimates actuals. Last year September 14, 2020 ( Updated on February 01, 2021 ) Buy or Candidate!, news, financials, charts and other important investing information stock prices, earnings estimates & actuals on! Wells Fargo Affirms “ an Overweight ” Ranking to Anaplan Inc. ( KALA ) stock prediction. To within 12 months ( a possible kala stock price target % upside ) and 0 Hold ratings flow expected by investors! Kala ) was reported by Jefferies on 2020-09-14 “ an Overweight ” Ranking to Inc.... Pharmaceuticals Inc has a higher such ratio than 95.87 % of stocks in our set Candidate after Monday trading.... By the investors since 2021-01-27 Loss -1.03 % PDF '' rating on November 30, 2020, Jefferies Recapitulated Hold. Collected 14.03 % of gains in the last 24 hours published its report on Thursday October! Same analysts give the stock while placing it at a high target of $ 8,711.15.KALA price is down -2.2 in. Street have posted such Reports regarding the KALA shares 24-hour trading volume of $ 20.00 share!

Carrie Mae Weems Equivalents, Roster Of Raptors 2019, Anna I Robert Lewandowscy, How To Get To Herm Island, Toy Story Kingdom Hearts, Royal Mint Legal Tender, Pompey Fans Fighting,